Skip to main content
    J

    Jupiter Neurosciences, Inc. Common Stock (JUNS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.70
    -0.06 (-3.41%)

    Market Cap: $2.32M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Jupiter Neurosciences, Inc. Common Stock (JUNS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Jupiter Neurosciences, Inc. Common Stock are Revelation Biosciences (REVB), Neurosense Therapeutics (NRSN) and BioRestorative Therapies (BRTX). By market cap, Jupiter Neurosciences, Inc. Common Stock ranks 8th of the 13 companies on this page; Jaguar Animal Health (JAGX) is the largest at $5.59M.

    Peer Comparison

    JUNS's ROIC of 1154.5% is above the peer median of -98.4%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Jupiter Neurosciences, Inc. Common Stock (JUNS)$2.32MN/A21.0x0.0%1154.5%0.0%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    Neurosense Therapeutics Ltd (NRSN)$3.21MN/AN/A0.0%N/A0.0%0.00%
    BioRestorative Therapies Inc (BRTX)$2.06MN/A70.3x0.0%-289.9%-7.3%0.00%
    Genprex Inc (GNPX)$1.71MN/AN/A0.0%N/A0.0%0.00%
    GRI Bio Inc. (GRI)$3.72MN/AN/A0.0%N/A0.0%0.00%
    Purple Biotech (PPBT)$2.65MN/AN/A0.0%-156.2%0.0%0.00%
    Reviva Pharmaceuticals Holdings Inc. (RVPH)$4.63MN/AN/A0.0%-90.2%0.0%0.00%
    Enlivex Therapeutics Ltd (ENLV)$1.82MN/AN/A0.0%-0.3%0.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    Jaguar Animal Health Inc (JAGX)$5.59MN/AN/A-130.8%-98.4%-58.9%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)$1.82MN/A1.7x0.0%N/A-32.5%0.00%
    Peer median$2.54MN/A36.0x0.0%-98.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Jupiter Neurosciences, Inc. Common Stock, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Revelation Biosciences Inc (REVB)
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    Neurosense Therapeutics Ltd (NRSN)
    Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases...
    BioRestorative Therapies Inc (BRTX)
    BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue...
    BRTX competitors
    Genprex Inc (GNPX)
    Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes.
    GNPX competitors
    GRI Bio Inc. (GRI)
    GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology.
    GRI competitors
    Purple Biotech (PPBT)
    Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United...
    PPBT competitors
    Reviva Pharmaceuticals Holdings Inc. (RVPH)
    Reviva Pharmaceuticals Holdings Inc. (RVPH) is a clinical-stage biopharmaceutical company dedicated to developing groundbreaking therapies for central nervous...
    RVPH competitors
    Enlivex Therapeutics Ltd (ENLV)
    Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel.
    ENLV competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    Jaguar Animal Health Inc (JAGX)
    Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset...
    JAGX competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)
    60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention...
    SXTP competitors

    Frequently Asked Questions About JUNS

    Who are Jupiter Neurosciences, Inc. Common Stock's main competitors?

    The companies most similar to Jupiter Neurosciences, Inc. Common Stock include Revelation Biosciences (REVB), Neurosense Therapeutics (NRSN), BioRestorative Therapies (BRTX), Genprex (GNPX) and GRI Bio (GRI), listed from the closest match.

    Who is Jupiter Neurosciences, Inc. Common Stock's biggest competitor?

    Jaguar Animal Health (JAGX) is the largest of the similar companies at $5.59M; Revelation Biosciences (REVB) is the closest match by business profile, size, sector and industry.

    How does JUNS stock compare with its competitors?

    JUNS' P/S is 21.0x against a peer median of 36.0x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Jupiter Neurosciences, Inc. Common Stock's competitors pays a higher dividend?

    Jupiter Neurosciences, Inc. Common Stock pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Jupiter Neurosciences, Inc. Common Stock bigger than its competitors?

    No. Jupiter Neurosciences, Inc. Common Stock is 8th by market cap among the 13 companies on this page; the largest is Jaguar Animal Health (JAGX) at $5.59M.